Veracyte, Inc. logo

Veracyte, Inc.

NASDAQ:VCYT

Overview | Financials
Company Name Veracyte, Inc.
Symbol VCYT
Currency USD
Price 31.51
Market Cap 2,456,040,648
Dividend Yield 0%
52-week-range 18.61 - 47.316
Industry Biotechnology
Sector Healthcare
CEO Mr. Marc A. Stapley
Website https://www.veracyte.com

An error occurred while fetching data.

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer

Related Stocks

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

Exscientia plc logo

Exscientia plc

EXAI

4.84 USD

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

4.2 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.175 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

13.74 USD

CareDx, Inc logo

CareDx, Inc

CDNA

18.9 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

3.66 USD

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

1.22 USD

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

20.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD